MYC Degradation
Open accessThe DOI matches its Crossref record; 111 of the 114 references it cites were found in a registry or an index.
Abstract
The MYC oncoprotein is an essential transcription factor that regulates the expression of many genes involved in cell growth, proliferation, and metabolic pathways. Thus, it is important to keep MYC activity in check in normal cells in order to avoid unwanted oncogenic changes. Normal cells have adapted several ways to control MYC levels, and these mechanisms can be disrupted in cancer cells. One of the major ways in which MYC levels are controlled in cells is through targeted degradation by the ubiquitin-proteasome system (UPS). Here, we discuss the role of the UPS in the regulation of MYC protein levels and review some of the many proteins that have been shown to regulate MYC protein stability. In addition, we discuss how this relates to MYC transcriptional activity, human cancers, and therapeutic targeting.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“We show that DT-061 binds a unique heterotrimeric regulatory pocket to selectively stabilize the B56α-PP2A holoenzyme thereby inducing cell death and attenuating tumor growth through B56α directed substrate dephosphorylation, including its most well characterized substrate, the oncogenic protein c-MYC (Allen-Petersen et al., 2018; Arnold and Sears, 2006; Farrell and Sears, 2014; Sheppard et al., 2”
From Selective PP2A enhancement through biased heterotrimer stabilization (2020) · cites this paper as Farrell and Sears, 2014
Citations
Cites
Function and regulation of cullin–RING ubiquitin ligases
Petroski, M. D., & Deshaies, R. J. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1547 · Cited by 2,148
Fraga, M. F., Ballestar, E., Villar-Garea, A., Boix-Chornet, M., Espada, J., Schotta, G., Bonaldi, T., Haydon, C., Ropero, S., Petrie, K., et al. (2005) · Nature Genetics · doi:10.1038/ng1531 · Cited by 1,923
A genomic and functional inventory of deubiquitinating enzymes.
Nijman, S. M. B., Luna-Vargas, M. P. A., Velds, A., Brummelkamp, T. R., Dirac, A. M. G., Sixma, T. K., & Bernards, R. (2005) · Cell · doi:10.1016/j.cell.2005.11.007 · Cited by 1,854
c-Myc Target Genes Involved in Cell Growth, Apoptosis, and Metabolism
Dang, C. V. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.1.1 · Cited by 1,715
Max: A Helix-Loop-Helix Zipper Protein That Forms a Sequence-Specific DNA-Binding Complex with Myc
Blackwood, E. M., & Eisenman, R. N. (1991) · Science · doi:10.1126/science.2006410 · Cited by 1,697
Transcriptional Amplification in Tumor Cells with Elevated c-Myc
Lin, C. Y., Lovén, J., Rahl, P. B., Paranal, R. M., Burge, C. B., Bradner, J. E., Lee, T. I., & Young, R. A. (2012) · Cell · doi:10.1016/j.cell.2012.08.026 · Cited by 1,513
Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability
Sears, R., Nuckolls, F., Haura, E., Taya, Y., Tamai, K., & Nevins, J. R. (2000) · Genes & Development · doi:10.1101/gad.836800 · Cited by 1,393
Self-citationc-Myc Regulates Transcriptional Pause Release
Rahl, P. B., Lin, C. Y., Seila, A. C., Flynn, R. A., McCuine, S., Burge, C. B., Sharp, P. A., & Young, R. A. (2010) · Cell · doi:10.1016/j.cell.2010.03.030 · Cited by 1,279
SCF and Cullin/RING H2-Based Ubiquitin Ligases
Deshaies, R. J. (1999) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.15.1.435 · Cited by 1,242
MYC oncogenes and human neoplastic disease
Nesbit, C. E., Tersak, J. M., & Prochownik, E. V. (1999) · Oncogene · doi:10.1038/sj.onc.1202746 · Cited by 1,158
Yamaoka, S., Courtois, G., Bessia, C., Whiteside, S. T., Weil, R., Agou, F., Kirk, H. E., Kay, R. J., & Israël, A. (1998) · Cell · doi:10.1016/s0092-8674(00)81466-x · Cited by 1,076
A family of proteins structurally and functionally related to the E6-AP ubiquitin-protein ligase.
Huibregtse, J. M., Scheffner, M., Beaudenon, S., & Howley, P. M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.7.2563 · Cited by 1,013
Ballinger, C. A., Connell, P., Wu, Y., Hu, Z., Thompson, L. J., Yin, L.-Y., & Patterson, C. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.6.4535 · Cited by 943
Welcker, M., Orian, A., Jin, J., Grim, J. A., Harper, J. W., Eisenman, R. N., & Clurman, B. E. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402770101 · Cited by 941
Phosphorylation‐dependent degradation of c‐Myc is mediated by the F‐box protein Fbw7
Yada, M., Hatakeyama, S., Kamura, T., Nishiyama, M., Tsunematsu, R., Imaki, H., Ishida, N., Okumura, F., Nakayama, K., & Nakayama, K. I. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600217 · Cited by 808
Yeh, E., Cunningham, M., Arnold, H., Chasse, D., Monteith, T., Ivaldi, G., Hahn, W. C., Stukenberg, P. T., Shenolikar, S., Uchida, T., et al. (2004) · Nature Cell Biology · doi:10.1038/ncb1110 · Cited by 791
Self-citationThe ubiquitin-proteasome system
Nandi, D., Tahiliani, P., Kumar, A., & Chandu, D. (2006) · Journal of Biosciences · doi:10.1007/bf02705243 · Cited by 758
The prolyl isomerase PIN1: a pivotal new twist in phosphorylation signalling and disease
Lu, K. P., & Zhou, X. Z. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2261 · Cited by 682
CIP2A inhibits PP2A in human malignancies
Junttila, M. R., Puustinen, P., Niemelä, M., Ahola, R., Arnold, H., Böttzauw, T., Ala-aho, R., Nielsen, C., Ivaska, J., Taya, Y., et al. (2007) · Cell · doi:10.1016/j.cell.2007.04.044 · Cited by 677
Self-citationSirT2 is a histone deacetylase with preference for histone H4 Lys 16 during mitosis
Vaquero, A., Scher, M. B., Lee, D. H., Sutton, A., Cheng, H.-L., Alt, F. W., Serrano, L., Sternglanz, R., & Reinberg, D. (2006) · Genes & Development · doi:10.1101/gad.1412706 · Cited by 665
HECT and RING finger families of E3 ubiquitin ligases at a glance
Metzger, M. B., Hristova, V. A., & Weissman, A. M. (2012) · Journal of Cell Science · doi:10.1242/jcs.091777 · Cited by 630
Extreme instability of myc mRNA in normal and transformed human cells.
Dani, C., Blanchard, J. M., Piechaczyk, M., El Sabouty, S., Marty, L., & Jeanteur, P. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.22.7046 · Cited by 516
Protein phosphatase 2A regulatory subunits and cancer
Eichhorn, P. J. A., Creyghton, M. P., & Bernards, R. (2009) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2008.05.005 · Cited by 513
Skp2 is oncogenic and overexpressed in human cancers
Gstaiger, M., Jordan, R., Lim, M., Catzavelos, C., Mestan, J., Slingerland, J., & Krek, W. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081474898 · Cited by 505
Acetylation of p53 inhibits its ubiquitination by Mdm2
Li, M., Luo, J., Brooks, C. L., & Gu, W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200578200 · Cited by 503
Proteins encoded by the human c-myc oncogene: differential expression in neoplastic cells.
Hann, S. R., & Eisenman, R. N. (1984) · Molecular and Cellular Biology · doi:10.1128/mcb.4.11.2486 · Cited by 495
Phosphorylation by Glycogen Synthase Kinase-3 Controls c-Myc Proteolysis and Subnuclear Localization
Gregory, M. A., Qi, Y., & Hann, S. R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m310722200 · Cited by 475
The ubiquitin-specific protease USP28 is required for MYC stability
Popov, N., Wanzel, M., Madiredjo, M., Zhang, D., Beijersbergen, R., Bernards, R., Moll, R., Elledge, S. J., & Eilers, M. (2007) · Nature Cell Biology · doi:10.1038/ncb1601 · Cited by 474
Gregory, M. A., & Hann, S. R. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.7.2423-2435.2000 · Cited by 469
Ras Enhances Myc Protein Stability
Sears, R., Leone, G., DeGregori, J., & Nevins, J. R. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80308-1 · Cited by 460
Self-citationEvasion of the p53 tumour surveillance network by tumour-derived MYC mutants
Hemann, M. T., Bric, A., Teruya-Feldstein, J., Herbst, A., Nilsson, J. A., Cordon-Cardo, C., Cleveland, J. L., Tansey, W. P., & Lowe, S. W. (2005) · Nature · doi:10.1038/nature03845 · Cited by 452
Salghetti, S. E. (1999) · The EMBO Journal · doi:10.1093/emboj/18.3.717 · Cited by 443
Skp2 Regulates Myc Protein Stability and Activity
Kim, S. Y., Herbst, A., Tworkowski, K. A., Salghetti, S. E., & Tansey, W. P. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00173-4 · Cited by 440
Mechanisms of apoptosis by c-Myc
Prendergast, G. C. (1999) · Oncogene · doi:10.1038/sj.onc.1202727 · Cited by 430
The Life Cycle of C-Myc: From Synthesis to Degradation
Sears, R. C. (2004) · Cell Cycle · doi:10.4161/cc.3.9.1145 · Cited by 417
Self-citationSchwamborn, J. C., Berezikov, E., & Knoblich, J. A. (2009) · Cell · doi:10.1016/j.cell.2008.12.024 · Cited by 414
An amino-terminal c-myc domain required for neoplastic transformation activates transcription.
Kato, G. J., Barrett, J., Villa-Garcia, M., & Dang, C. V. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.11.5914 · Cited by 410
von der Lehr, N., Johansson, S., Wu, S., Bahram, F., Castell, A., Cetinkaya, C., Hydbring, P., Weidung, I., Nakayama, K., Nakayama, K. I., et al. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00193-x · Cited by 408
Adhikary, S., Marinoni, F., Hock, A., Hulleman, E., Popov, N., Beier, R., Bernard, S., Quarto, M., Capra, M., Goettig, S., et al. (2005) · Cell · doi:10.1016/j.cell.2005.08.016 · Cited by 403
DNA Copy Number Losses in Human Neoplasms
Knuutila, S., Aalto, Y., Autio, K., Björkqvist, A.-M., El-Rifai, W., Hemmer, S., Huhta, T., Kettunen, E., Kiuru-Kuhlefelt, S., Larramendy, M. L., et al. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65166-8 · Cited by 397
von Lindern, M., van Baal, S., Wiegant, J., Raap, A., Hagemeijer, A., & Grosveld, G. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.8.3346 · Cited by 387
Control of Smad7 Stability by Competition between Acetylation and Ubiquitination
Grönroos, E., Hellman, U., Heldin, C.-H., & Ericsson, J. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00639-1 · Cited by 383
Regulation of Transcriptional Activation Domain Function by Ubiquitin
Salghetti, S. E., Caudy, A. A., Chenoweth, J. G., & Tansey, W. P. (2001) · Science · doi:10.1126/science.1062079 · Cited by 356
The c-MYC Oncoprotein Is a Substrate of the Acetyltransferases hGCN5/PCAF and TIP60
Patel, J. H., Du, Y., Ard, P. G., Phillips, C., Carella, B., Chen, C.-J., Rakowski, C., Chatterjee, C., Lieberman, P. M., Lane, W. S., et al. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.24.10826-10834.2004 · Cited by 354
Multiple pathways regulated by the tumor suppressor PP2A in transformation
Westermarck, J., & Hahn, W. C. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2008.02.001 · Cited by 344
Identification of the human c-myc protein nuclear translocation signal.
Dang, C. V., & Lee, W. M. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.10.4048 · Cited by 337
Bahram, F., von der Lehr, N., Cetinkaya, C., & Larsson, L.-G. (2000) · Blood · doi:10.1182/blood.v95.6.2104 · Cited by 286
Bhatia, K., Huppi, K., Spangler, G., Siwarski, D., Iyer, R., & Magrath, I. (1993) · Nature Genetics · doi:10.1038/ng0993-56 · Cited by 285
Stimulation of c‐MYC transcriptional activity and acetylation by recruitment of the cofactor CBP
Vervoorts, J., Lüscher‐Firzlaff, J. M., Rottmann, S., Lilischkis, R., Walsemann, G., Dohmann, K., Austen, M., & Lüscher, B. (2003) · EMBO reports · doi:10.1038/sj.embor.embor821 · Cited by 281
Salghetti, S. E., Muratani, M., Wijnen, H., Futcher, B., & Tansey, W. P. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3118 · Cited by 261
Arnold, H. K., & Sears, R. C. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.7.2832-2844.2006 · Cited by 251
Self-citationThe prolyl isomerase Pin1 is a novel prognostic marker in human prostate cancer.
Ayala, G., Wang, D.-G., Wulf, G. M., Frolov, A., Li, R., Sowadski, J. M., Wheeler, T. M., Lu, K. P., & Bao, L. (2003) · PubMed · Cited by 250
A c-Myc–SIRT1 feedback loop regulates cell growth and transformation
Yuan, J., Minter-Dykhouse, K., & Lou, Z. (2009) · Journal of Cell Biology · doi:10.1083/jcb.200809167 · Cited by 232
Site-specific modulation of c-Myc cotransformation by residues phosphorylated in vivo.
Pulverer, B., Fisher, C., Vousden, K. H., Littlewood, T. D., Evan, G. I., & Woodgett, J. R. (1994) · PubMed · Cited by 228
Phosphorylation by Cdk2 is required for Myc to repress Ras-induced senescence in cotransformation
Hydbring, P., Bahram, F., Su, Y., Tronnersjö, S., Högstrand, K., von der Lehr, N., Sharifi, H. R., Lilischkis, R., Hein, N., Wu, S., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900121106 · Cited by 225
Conacci-Sorrell, M., Ngouenet, C., & Eisenman, R. N. (2010) · Cell · doi:10.1016/j.cell.2010.06.037 · Cited by 224
CIP2A Is Associated with Human Breast Cancer Aggressivity
Côme, C., Laine, A., Chanrion, M., Edgren, H., Mattila, E., Liu, X., Jonkers, J., Ivaska, J., Isola, J., Darbon, J.-M., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-3283 · Cited by 221
Lutterbach, B., & Hann, S. R. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.8.5510 · Cited by 220
Jin, Y.-H., Jeon, E.-J., Li, Q.-L., Lee, Y. H., Choi, J.-K., Kim, W.-J., Lee, K.-Y., & Bae, S.-C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313120200 · Cited by 211
The histone deacetylase SIRT2 stabilizes Myc oncoproteins
Liu, P. Y., Xu, N., Malyukova, A., Scarlett, C. J., Sun, Y. T., Zhang, X. D., Ling, D., Su, S.-P., Nelson, C., Chang, D. K., et al. (2013) · Cell Death & Differentiation · doi:10.1038/cdd.2012.147 · Cited by 207
Proteasome system of protein degradation and processing
Sorokin, A. V., Kim, E. R., & Ovchinnikov, L. P. (2009) · Biochemistry (Moscow) · doi:10.1134/s000629790913001x · Cited by 202
MYC-Dependent Regulation and Prognostic Role of CIP2A in Gastric Cancer
Khanna, A., Böckelman, C., Hemmes, A., Junttila, M. R., Wiksten, J.-P., Lundin, M., Junnila, S., Murphy, D. J., Evan, G. I., Haglund, C., et al. (2009) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djp103 · Cited by 185
Prolyl isomerase Pin1: a catalyst for oncogenesis and a potential therapeutic target in cancer
Ryo, A., Liou, Y.-C., Lu, K. P., & Wulf, G. (2003) · Journal of Cell Science · doi:10.1242/jcs.00276 · Cited by 173
Ubiquitylation of the amino terminus of Myc by SCFβ-TrCP antagonizes SCFFbw7-mediated turnover
Popov, N., Schülein‐Völk, C., Jaenicke, L. A., & Eilers, M. (2010) · Nature Cell Biology · doi:10.1038/ncb2104 · Cited by 173
Aire unleashes stalled RNA polymerase to induce ectopic gene expression in thymic epithelial cells
Giraud, M., Yoshida, H., Abramson, J., Rahl, P. B., Young, R. A., Mathis, D., & Benoist, C. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1119351109 · Cited by 172
Phosphorylation Regulates c-Myc's Oncogenic Activity in the Mammary Gland
Wang, X., Cunningham, M., Zhang, X., Tokarz, S., Laraway, B., Troxell, M., & Sears, R. C. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-1032 · Cited by 165
Self-citationCUL7: A DOC domain-containing cullin selectively binds Skp1⋅Fbx29 to form an SCF-like complex
Dias, D. C., Dolios, G., Wang, R., & Pan, Z.-Q. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.252646399 · Cited by 165
The ubiquitin ligase CHIP acts as an upstream regulator of oncogenic pathways
Kajiro, M., Hirota, R., Nakajima, Y., Kawanowa, K., So-ma, K., Ito, I., Yamaguchi, Y., Ohie, S.-H., Kobayashi, Y., Seino, Y., et al. (2009) · Nature Cell Biology · doi:10.1038/ncb1839 · Cited by 163
Large-Scale Identification of c-MYC-Associated Proteins Using a Combined TAP/MudPIT Approach
Koch, H., Zhang, R., Verdoodt, B., Bailey, A., Zhang, C.-D., Yates, J. R., Menssen, A., & Hermeking, H. (2007) · Cell Cycle · doi:10.4161/cc.6.2.3742 · Cited by 162
The ubiquitin ligase CHIP regulates c-Myc stability and transcriptional activity
Paul, I., Ahmed, S. F., Bhowmik, A., Deb, S., & Ghosh, M. K. (2013) · Oncogene · doi:10.1038/onc.2012.144 · Cited by 159
Proteolytic Control of the Oncoprotein Transcription Factor Myc
Thomas, L. R., & Tansey, W. P. (2011) · Advances in cancer research · doi:10.1016/b978-0-12-386469-7.00004-9 · Cited by 143
Farrell, A. S., Pelz, C., Wang, X., Daniel, C. J., Wang, Z., Su, Y., Janghorban, M., Zhang, X., Morgan, C. W., Impey, S., et al. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.01455-12 · Cited by 143
Self-citationChristensen, D. J., Chen, Y., Oddo, J., Matta, K. M., Neil, J. E., Davis, E. D., Volkheimer, A. D., Lanasa, M. C., Friedman, D. R., Goodman, B. K., et al. (2011) · Blood · doi:10.1182/blood-2011-04-351072 · Cited by 135
Myc-Mediated Transcriptional Repression by Recruitment of Histone Deacetylase
Kurland, J. F., & Tansey, W. P. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6552 · Cited by 135
The Drosophila F Box Protein Archipelago Regulates dMyc Protein Levels In Vivo
Moberg, K. H., Mukherjee, A., Veraksa, A. N., Artavanis‐Tsakonas, S., & Hariharan, I. K. (2004) · Current Biology · doi:10.1016/j.cub.2004.04.040 · Cited by 132
Flinn, E. M., Busch, C. M. C., & Wright, A. P. H. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.10.5961 · Cited by 131
Regulation of Skp2 Expression and Activity and Its Role in Cancer Progression
Chan, C., Lee, S.-W., Wang, J., & Lin, H.-K. (2010) · The Scientific World JOURNAL · doi:10.1100/tsw.2010.89 · Cited by 127
Fbw7 and Usp28 Regulate Myc Protein Stability in Response to DNA Damage
Popov, N., Herold, S., Prada, M. L., Schülein‐Völk, C., & Eilers, M. (2007) · Cell Cycle · doi:10.4161/cc.6.19.4804 · Cited by 125
Myc protein is stabilized by suppression of a novel E3 ligase complex in cancer cellsPreprint
Choi, S. H., Wright, J. B., Gerber, S. A., & Cole, M. D. (2010) · Genes & Development · doi:10.1101/gad.1920310 · Cited by 124
Prolyl isomerase Pin1 as a molecular target for cancer diagnostics and therapeutics
Lu, K. P. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00218-6 · Cited by 123
Isoform- and cell cycle–dependent substrate degradation by the Fbw7 ubiquitin ligase
Grim, J. E., Gustafson, M. P., Hirata, R. K., Hagar, A., Swanger, J., Welcker, M., Hwang, H. C., Ericsson, J., Russell, D. W., & Clurman, B. E. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200802076 · Cited by 119
The Axin1 scaffold protein promotes formation of a degradation complex for c‐Myc
Arnold, H., Zhang, X., Daniel, C. J., Tibbitts, D., Escamilla‐Powers, J. R., Farrell, A., Tokarz, S. A., Morgan, C. W., & Sears, R. C. (2009) · The EMBO Journal · doi:10.1038/emboj.2008.279 · Cited by 117
Self-citationSV40 small T antigen and PP2A phosphatase in cell transformation
Sablina, A. A., & Hahn, W. C. (2008) · Cancer and Metastasis Reviews · doi:10.1007/s10555-008-9116-0 · Cited by 115
Mechanisms of Tumor Suppression by the SCFFbw7
Minella, A. C., & Clurman, B. E. (2005) · Cell Cycle · doi:10.4161/cc.4.10.2058 · Cited by 115
Translational control of c-MYC by rapamycin promotes terminal myeloid differentiation
Wall, M., Poortinga, G., Hannan, K. M., Pearson, R. B., Hannan, R. D., & McArthur, G. A. (2008) · Blood · doi:10.1182/blood-2007-09-111856 · Cited by 106
The Fbxw7/hCdc4 tumor suppressor in human cancer
Tan, Y., Sangfelt, O., & Spruck, C. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.04.036 · Cited by 102
Aberrant stabilization of c-Myc protein in some lymphoblastic leukemias
Malempati, S., Tibbitts, D., Cunningham, M., Akkari, Y. M. N., Olson, S. B., Fan, G., & Sears, R. C. (2006) · Leukemia · doi:10.1038/sj.leu.2404317 · Cited by 102
Self-citationA conserved element in Myc that negatively regulates its proapoptotic activity
Herbst, A., Hemann, M. T., Tworkowski, K. A., Salghetti, S. E., Lowe, S. W., & Tansey, W. P. (2005) · EMBO Reports · doi:10.1038/sj.embor.7400333 · Cited by 100
Bretones, G., Acosta, J. C., Caraballo, J. M., Ferrándiz, N., Gómez‐Casares, M. T., Albajar, M., Blanco, R. E., Ruiz, P. S. B., Hung, W., Albero, M. P., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.165977 · Cited by 100
The prolyl isomerase Pin1 in breast development and cancer
Wulf, G. M., Ryo, A., Liou, Y., & Lu, K. P. (2003) · Breast Cancer Research · doi:10.1186/bcr572 · Cited by 87
Mechanistic insight into Myc stabilization in breast cancer involving aberrant Axin1 expression
Zhang, X., Farrell, A. S., Daniel, C. J., Arnold, H., Scanlan, C., Laraway, B. J., Janghorban, M., Lum, L., Chen, D., Troxell, M. L., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100764108 · Cited by 81
Self-citationRegulation of NF-κB activity by competition between RelA acetylation and ubiquitination
Li, H., Wittwer, T., Weber, A., Schneider, H., Moreno, R., Maine, G. N., Kracht, M., Schmitz, M. L., & Burstein, E. (2011) · Oncogene · doi:10.1038/onc.2011.253 · Cited by 74
Lam, P. B., Burga, L. N., Wu, B. P., Hofstatter, E. W., Lu, K. P., & Wulf, G. M. (2008) · Molecular Cancer · doi:10.1186/1476-4598-7-91 · Cited by 73
The myc Oncogene: Its Role in Transformation and Differentiation
Cole, M. (1986) · Annual Review of Genetics · doi:10.1146/annurev.genet.20.1.361 · Cited by 65
SET complex in serous epithelial ovarian cancer
Ouellet, V., Page, C. L., Guyot, M., Lussier, C., Tonin, P. N., Provencher, D. M., & Mes‐Masson, A. (2006) · International Journal of Cancer · doi:10.1002/ijc.22054 · Cited by 64
Đikić, I., & Robertson, M. (2012) · BMC Biology · doi:10.1186/1741-7007-10-22 · Cited by 60
Six lysine residues on c-Myc are direct substrates for acetylation by p300
Zhang, K., Faiola, F., & Martinez, E. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.08.075 · Cited by 59
Bachireddy, P., Bendapudi, P. K., & Felsher, D. W. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0534 · Cited by 59
The peptidyl-prolyl isomerase Pin1.
Joseph, J. D., Yeh, E. S., Swenson, K. I., Means, A. R., & Winkler (2003) · PubMed · Cited by 57
Miyashita, H., Mori, S., Motegi, K., Fukumoto, M., & Uchida, T. (2003) · Oncology Reports · doi:10.3892/or.10.2.455 · Cited by 56
PP2A-B56α controls oncogene-induced senescence in normal and tumor human melanocytic cells
Mannava, S., Omilian, A. R., Wawrzyniak, J. A., Fink, E. E., Zhuang, D., Miecznikowski, J. C., Marshall, J. R., Soengas, M. S., Sears, R. C., Morrison, C., et al. (2011) · Oncogene · doi:10.1038/onc.2011.339 · Cited by 52
Self-citationMultiple cell-type-specific elements regulate Myc protein stability
Herbst, A., Salghetti, S. E., Kim, S. Y., & Tansey, W. P. (2004) · Oncogene · doi:10.1038/sj.onc.1207492 · Cited by 52
Salghetti, S. E. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.050007597 · Cited by 42
Evidence for involvement of calpain in c-Myc proteolysis in vivo
Small, G. W., Chou, T., Dang, C. V., & Orlowski, R. Z. (2002) · Archives of Biochemistry and Biophysics · doi:10.1016/s0003-9861(02)00005-x · Cited by 39
Post-translational control of Myc function during differentiation
Conacci‐Sorrell, M., & Eisenman, R. N. (2011) · Cell Cycle · doi:10.4161/cc.10.4.14794 · Cited by 34
Lobo, V. J. S.-A., Doni, M., Verrecchia, A., Sanulli, S., Fagà, G., Piontini, A., Bianchi, M., Conacci‐Sorrell, M., Mazzarol, G., Peg, V., et al. (2013) · Oncogene · doi:10.1038/onc.2012.621 · Cited by 28
A Nucleolar Isoform of the Fbw7 Ubiquitin Ligase Regulates c-Myc and Cell Size
Welcker, M., Orian, A., Grim, J. E., Eisenman, R. N., & Clurman, B. E. (2005) · Current Biology · doi:10.1016/j.cub.2005.12.001 · Cited by 23
Molecular Analysis of the c‐myc Transcription Elongation Block
Spencer, C. A., & Groudine, M. T. (1990) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1990.tb42360.x · Cited by 16
Han, Y. (2011) · Oncology Reports · doi:10.3892/or.2011.1432 · Cited by 13
NEMO stabilizes c‐Myc through direct interaction in the nucleus
Kim, B.-Y., Yang, J.-S., Kwak, S.-Y., Zhang, X.-K., & Han, Y.-H. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.10.031 · Cited by 11
Kimura, T., Ishizuka, H., Yoshida, A., Morii, M., Takeguchi, N., & Asano, S. (2003) · Biochemistry · doi:10.1021/bi020513d · Cited by 4
Cited by
Stine, Z. E., Walton, Z. E., Altman, B. J., Hsieh, A. L., & Dang, C. V. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0507 · Cited by 1,375
Drugging the ‘undruggable’ cancer targets
Dang, C. V., Reddy, E. P., Shokat, K. M., & Soucek, L. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.36 · Cited by 927
“Similarly, the specificity of targeting MYC protein stability is challenging 29 .”
KRAS: The Critical Driver and Therapeutic Target for Pancreatic Cancer
Waters, A. M., & Der, C. J. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a031435 · Cited by 875
Huang, M., & Weiss, W. A. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a014415 · Cited by 647
Therapeutic targeting of “undruggable” MYC
Llombart, V., & Mansour, M. R. (2022) · eBioMedicine · doi:10.1016/j.ebiom.2021.103756 · Cited by 472
Metadata
- Authors
- Farrell, A. S., & Sears, R. C.
- Affiliations
- Oregon Health & Science University (US)
- ORCID
- Sears, R. C.
- Venue
- Cold Spring Harbor Perspectives in Medicine
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2014-03-01
- Volume
- 4
- Issue
- 3
- Pages
- a014365-a014365
- ISSN
- 2157-1422 (ISSN-L)
- PMC
- PMC3935390
- OpenAlex
- W4236967220
- Cited by
- 468
- References
- 114
- Citations by year
- 2026: 35 · 2025: 38 · 2024: 46 · 2023: 58 · 2022: 58 · 2021: 53 · 2020: 55 · 2019: 29 · 2018: 28 · 2017: 17 · 2016: 20 · 2015: 17 · 2014: 10
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cold Spring Harbor Perspectives in Medicine (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
- Keywords
- Myc oncoprotein, protein degradation, ubiquitin-proteasome system, MYC protein stability, transcriptional regulation, cancer, MYC-targeted therapy, cell proliferation
- MeSH terms
- Acetylation, Cell Communication, Humans, Neoplasms, Transcription, Genetic, Genes, myc, Ubiquitin, Proteasome Endopeptidase Complex, Protein Stability, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.